Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:294 (31 July), doi:10.1136/bmj.329.7460.294-a
| The first 150 words of the full text of this article appear below. |
EDITORThe campaign to revitalise academic medicine may well demand radical thinking.1 Many expect or hope for a continuation of the long term expansion of medical research funding, but consider the fate of physics.
Physics was once the richest, most self confident, and most prestigious science. The first half of the 20th century was a golden age for its science, the time after the second world war a golden age for funding. Achievements did not match the hype, and support for physics has collapsed, fundamental physics research now being pursued in only a few universities in the United Kingdom.
Similarly, the middle of the 20th century was the golden age for clinical breakthroughs and biological science, which was followed by massive expansion in research funding. But the rate of major clinical advances has not lived up to the spin.2 The Human Genome Project was the costliest biological venture in
Bruce G Charlton, editor in chief
Medical Hypotheses Bruce.Charlton@newcastle.ac.uk
Peter Andras, lecturer
School of Computing Science Henry Wellcome Building, School of Biology, University of Newcastle upon Tyne, Newcastle upon Tyne NE1 7RU